We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+24.92%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$121M
AUM Growth
+$12.8M
Cap. Flow
-$3.03M
Cap. Flow %
-2.51%
Top 10 Hldgs %
72.03%
Holding
125
New
60
Increased
12
Reduced
11
Closed
25

Sector Composition

Rank Sector Weight
1 Technology 43.2%
2 Healthcare 20.87%
3 Financials 13.46%
4 Consumer Discretionary 9.87%
5 Communication Services 0.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DELL icon
1
Dell
DELL
$242B
$37.4M 30.97%
1,342,877
WTW icon
2
Willis Towers Watson
WTW
$29.9B
$8.09M 6.7%
41,056
+20,556
+100% +$3.94M
TECD
3
DELISTED
Tech Data Corp
TECD
$7.91M 6.55%
54,600
+25,500
+88% +$3.53M
BABA icon
4
Alibaba
BABA
$277B
$7.76M 6.43%
36,000
+400
+1% +$83.3K
AMTD
5
DELISTED
TD Ameritrade Holding Corp
AMTD
$6.64M 5.5%
182,630
+23,000
+14% +$866K
TIF
6
DELISTED
Tiffany & Co.
TIF
$6.23M 5.16%
51,092
+26,192
+105% +$3.28M
CZR
7
DELISTED
Caesars Entertainment Corporation
CZR
$4.15M 3.44%
+342,418
New +$3.46M
ACIA
8
DELISTED
Acacia Communications Inc
ACIA
$2.98M 2.47%
44,365
FIT
9
DELISTED
Fitbit, Inc. Class A common stock
FIT
$2.91M 2.41%
451,000
WMGI
10
DELISTED
Wright Medical Group Inc
WMGI
$2.91M 2.41%
+97,960
New +$2.86M
LOGM
11
DELISTED
LogMein, Inc.
LOGM
$2.89M 2.39%
+34,109
New +$2.89M
INDA icon
12
iShares MSCI India ETF
INDA
$6.81B
$1.48M 1.23%
51,100
+200
+0.4% +$5.36K
GNW icon
13
Genworth Financial
GNW
$3.86B
$1.33M 1.11%
578,000
SMIN icon
14
iShares MSCI India Small-Cap ETF
SMIN
$753M
$1.14M 0.95%
39,100
-7,000
-15% -$182K
AXSM icon
15
Axsome Therapeutics
AXSM
$11.8B
$571K 0.47%
+6,941
New +$534K
CCXI
16
DELISTED
ChemoCentryx, Inc.
CCXI
$562K 0.47%
+9,769
New +$532K
PRNB
17
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$548K 0.45%
+9,165
New +$566K
ADVM
18
DELISTED
Adverum Biotechnologies
ADVM
$547K 0.45%
+2,620
New +$464K
DRNA
19
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$538K 0.45%
+21,201
New +$457K
RCKT icon
20
Rocket Pharmaceuticals
RCKT
$336M
$524K 0.43%
+25,024
New +$451K
DBC icon
21
Invesco DB Commodity Index Tracking Fund
DBC
$1.69B
$522K 0.43%
42,396
TGTX icon
22
TG Therapeutics
TGTX
$8.25B
$512K 0.42%
+26,269
New +$423K
TSM icon
23
TSMC
TSM
$1.97T
$505K 0.42%
8,900
-1,000
-10% -$52.7K
EIDX
24
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$505K 0.42%
+10,596
New +$493K
ARVN icon
25
Arvinas
ARVN
$530M
$485K 0.4%
+14,467
New +$614K

Similar funds

HighVista Strategies's Q2 2020 Portfolio in Review

As of Q2 2020, HighVista Strategies held 125 positions worth $121M, up 12% from $108M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

HighVista Strategies's Q2 2020 filing shows 60 new, 12 increased, 11 reduced and 25 closed positions. Its largest new stake was Caesars Entertainment Corporation: 342,418 shares worth $4.15M. The largest sale was Allergan plc, an estimated $19.3M.

By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 40% a quarter earlier, followed by Healthcare and Financials.

  • HighVista Strategies's largest Q2 2020 buy was Caesars Entertainment Corporation: 342,418 shares worth $4.15M.
  • HighVista Strategies added most to Willis Towers Watson in Q2 2020, an estimated $3.94M increase.
  • HighVista Strategies's biggest Q2 2020 reduction was Silvergate Capital Corporation, cutting an estimated $2.58M.
  • HighVista Strategies fully exited Allergan plc in Q2 2020, selling an estimated $19.3M.
  • HighVista Strategies's ten largest holdings make up 72% of its $121M portfolio in Q2 2020.
  • HighVista Strategies opened 60 new positions and closed 25 in Q2 2020.
  • HighVista Strategies's portfolio value rose 12% quarter-over-quarter to $121M.

Based on HighVista Strategies's 13F filing for Q2 2020, filed 14 Aug 2020.